ArticleFrontiers in surgery2026
Total hip arthroplasty in patients with alkaptonuria: a case report.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alkaptonuria (AKU) is a rare autosomal recessive disorder caused by mutations in the homogentisate 1,2-dioxygenase (HGD) gene, often leading to debilitating ochronotic arthropathy that requires total joint arthroplasty (THA). This case report describes a 56-year-old male patient with AKU who underwent THA due to end-stage arthropathy. Genetic testing revealed that the subject carried a c.157C > T (p.Arg53Trp) variant, a missense variant in the coding region of the HGD gene, and a c.880-9T > A variant, a single base substitution in the intronic region of the HGD gene. Both were classified as variants of uncertain significance (VUS). The preoperative Visual Analog Scale (VAS) score was 4, which decreased to 2 by postoperative day 5 and reached 0 at the 1-month follow-up. At six months postoperatively, the patient reported no pain, free hip range of motion, and high satisfaction. For patients with ochronotic end-stage arthropathy, arthroplasty can achieve favorable early clinical outcomes, although longer follow-up is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.